Filing Details
- Accession Number:
- 0001596771-15-000010
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-01-15 16:55:32
- Reporting Period:
- 2014-10-09
- Filing Date:
- 2015-01-15
- Accepted Time:
- 2015-01-15 16:55:32
- Original Submission Date:
- 2014-10-10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1610092 | Diplomat Pharmacy Inc. | DPLO | Retail-Drug Stores And Proprietary Stores (5912) | 382063100 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619009 | M Jeffrey Rowe | 4100 S. Saginaw Street Flint MI 48507 | Evp Of Operations | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-09 | 270,833 | $13.00 | 1,600,284 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-09 | 270,833 | $13.00 | 281,667 | No | 4 | S | Indirect | Rowe Family Trusts |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | Rowe Family Trusts |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 59,500 | Indirect | Irrevocable Exempt Trust for Daughter |
Common Stock | 59,500 | Indirect | Irrevocable Exempt Trust for Son |
Common Stock | 59,500 | Indirect | Irrevocable Exempt Trust for Son |
Common Stock | 59,500 | Indirect | Irrevocable Exempt Trust for Daughter |
Common Stock | 59,500 | Indirect | Irrevocable Exempt Trust for Son |
Common Stock | 127,500 | Indirect | Rowe Charitable Remainder Unitrust |
Footnotes
- These shares were sold as part of the initial public offering of the Issuer's common stock. This amendment reflects the additional shares sold in the initial public offering pursuant to the underwriters' exercise of an option to purchase such shares in connection with such offering; the additional sale of shares was inadvertently omitted from the initial filing.